rs41457746
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000517.6(HBA2):c.96-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 9)
Exomes 𝑓: 0.000041 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
HBA2
NM_000517.6 splice_acceptor, intron
NM_000517.6 splice_acceptor, intron
Scores
2
2
3
Splicing: ADA: 1.000
2
Clinical Significance
Conservation
PhyloP100: 8.62
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, Cryptic splice site detected, with MaxEntScore 3.4, offset of 28, new splice context is: tgtccttccccaccaccaAGacc. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
PP5
Variant 16-173123-A-G is Pathogenic according to our data. Variant chr16-173123-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 15679.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-173123-A-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBA2 | NM_000517.6 | c.96-2A>G | splice_acceptor_variant, intron_variant | ENST00000251595.11 | NP_000508.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBA2 | ENST00000251595.11 | c.96-2A>G | splice_acceptor_variant, intron_variant | 1 | NM_000517.6 | ENSP00000251595.6 | ||||
HBA2 | ENST00000484216.1 | c.63-2A>G | splice_acceptor_variant, intron_variant | 1 | ENSP00000495899.1 | |||||
HBA2 | ENST00000482565.1 | n.230A>G | non_coding_transcript_exon_variant | 1/2 | 1 | |||||
HBA2 | ENST00000397806.1 | c.-1-2A>G | splice_acceptor_variant, intron_variant | 2 | ENSP00000380908.1 |
Frequencies
GnomAD3 genomes AF: 0.0000332 AC: 2AN: 60196Hom.: 0 Cov.: 9
GnomAD3 genomes
AF:
AC:
2
AN:
60196
Hom.:
Cov.:
9
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000409 AC: 23AN: 562962Hom.: 0 Cov.: 7 AF XY: 0.0000539 AC XY: 16AN XY: 297030
GnomAD4 exome
AF:
AC:
23
AN:
562962
Hom.:
Cov.:
7
AF XY:
AC XY:
16
AN XY:
297030
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000332 AC: 2AN: 60196Hom.: 0 Cov.: 9 AF XY: 0.00 AC XY: 0AN XY: 27086
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
2
AN:
60196
Hom.:
Cov.:
9
AF XY:
AC XY:
0
AN XY:
27086
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 28, 2023 | The IVS-I-116 variant (HBA2: c.96-2A>G, HbVar ID: 1066, rs41457746) is reported in the literature in multiple individuals affected with alpha (+) thalassemia in the heterozygous state (see HbVar and references therein, Bayat 2013). This variant was observed in trans with the alpha 3.7 deletion in an individual with alpha thalassemia with Hb H inclusion bodies (Harteveld 2003). Additionally, this variant was detected in a fetus with Hb H disease in trans with the Southeast Asian deletion (--SEA) (He 2018). This variant is also reported in ClinVar (Variation ID: 15679). This variant is only observed on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. This variant disrupts the canonical splice acceptor site of intron one, which is likely to negatively impact gene function. Analyses of the variant transcript show intron one is retained leading to a premature stop codon and post-transcriptional instability (Harteveld 1996). Based on available information, this variant is considered to be pathogenic. References: Link to HbVar: https://globin.bx.psu.edu/hbvar/menu.html Bayat N et al. Novel mutations responsible for alpha-thalassemia in Iranian families. Hemoglobin. 2013;37(2):148-59. PMID: 23402770. Harteveld CL et al. An IVS1-116 (A-->G) acceptor splice site mutation in the alpha 2 globin gene causing alpha + thalassaemia in two Dutch families. Br J Haematol. 1996 Dec;95(3):461-6. PMID: 8943885. Harteveld CL et al. The Dutch IVS-I-116 (A --> G) (alpha2) thalassemia mutation induces Hb H inclusion bodies when found in combination with the -alpha3.7 deletion defect. Hemoglobin. 2003 Feb;27(1):49-51. PMID: 12603095. He XH et al. First Report of a Case with Nondeletional Hb H Disease Caused by IVS-I-116 (A>G) of the alpha2-Globin Gene. Hemoglobin. 2018 Sep-Nov;42(5-6):344-346. PMID: 30676123. - |
Pathogenic, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
alpha Thalassemia;C0700299:Heinz body anemia;C3161174:Hemoglobin H disease;C4693823:Erythrocytosis, familial, 7 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 05, 2021 | - - |
Alpha-thalassemia, Dutch type Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2003 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Benign
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 30
DS_AL_spliceai
Position offset: 2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at